Ladenburg Thalmann Boosts Price Target on BioDelivery Sciences (BDSI) to $9

Ladenburg Thalmann raises its price target on BioDelivery Sciences International Inc. (Nasdaq: BDSI) from $6.5 to $9, reiterating their Buy rating.

BioDelivery Sciences International, Inc. operates as a specialty pharmaceutical company in the United States.

Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php

You May Also Be Interested In

• Canaccord Genuity Maintains a 'Hold' on Tiffany & Co. (TIF); Cutting PT and Estimates
• Barclays Reiterates an 'Equalweight' on Lexington Realty Trust (LXP); Growing Pipeline, But Waiting on Cash in 2013
• Barclays Cuts Estimates and Price Target on ADP (ADP); Mixed Data From Investor Day

Create E-mail Alert Related Categories

Analyst Comments

Related Entities

Ladenburg Thalmann Financial Services

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter